United Therapeutics (Nasdaq: UTHR) is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Their public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. Founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH), the company now has six FDA-approved therapies for PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD), and neuroblastoma. Their near-term pipeline focuses on additional therapies for PAH and pulmonary fibrosis (PF). United Therapeutics is also working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers for transplant, aiming to eliminate the transplant waiting list and cure end-stage organ diseases. The Senior Scientific Review & Medical Communications Manager will serve as the lead medical reviewer for pulmonary hypertension (PH) related promotional materials, sales training materials, and other external-use content, ensuring compliance, scientific and medical accuracy, and alignment with Company and Global Medical Affairs strategy. The ideal candidate is a collaborative communicator, capable of interpreting complex data and compliantly disseminating it across various formats and audiences.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Senior
Education Level
Ph.D. or professional degree